Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Materials (Basel, Switzerland)|April 17, 2019
Pitting Corrosion of Natural Aged Al⁻Mg⁻Si Extrusion ProfileQuanmei Guan, Jing Sun, William Yi Wang, et al.
Occupational and Environmental Medicine|October 23, 2015
Long-term exposure to diesel engine exhaust induces primary DNA damage: a population-based studyHuawei Duan, Xiaowei Jia, Qingfeng Zhai, et al.
Journal of Cellular and Molecular Medicine|October 30, 2015
Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stressChi Zhang, Fan Wang, Yingxia Zhang, et al.
Molecular Therapy. Nucleic Acids|May 11, 2026
ClinASO: An open-source platform for rapid drug discovery of gapmer antisense oligonucleotidesShunkai Chen, Hao Liu, Dezi Cong, et al.
Toxicology Research|August 10, 2018
Long-term exposure to diesel engine exhaust affects cytokine expression among occupational populationYufei Dai, Xiao Zhang, Rong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2016
Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosisGui-Bai Liang, Changyou Zhou, Xianghong Huo, et al.
Bioscience, Biotechnology, and Biochemistry|March 9, 2021
Study on the effect of Mongolian medicine Qiwei Qinggan Powder on hepatic fibrosis through JAK2/STAT3 pathwayJie Liang, Hongwei Yuan, Liping Xu, et al.
Insights Into Imaging|January 26, 2026
Deep learning in differentiating the colorectal cancer combined with hepatic enhancing nodules: liver metastases vs hemangiomasShenglin Li, Shanshan Zhang, Yuebo Wang, et al.
Frontiers of Medicine|April 28, 2021
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trialLi Ni, Zheng Wen, Xiaowen Hu, et al.
Journal of Medicinal Chemistry|August 6, 2019
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.
Pageof 10